I agree 100% on the suspect management for 2 reasons. 1- on BAX 2q call they said they expected a CRL soon, but no mention from HALO about this. 2- Roche said they were moving forward with MabThera etc, but again no mention of this by HALO Not the kind of company I want to invest in. Clearly something was up and they chose to say nothing instead of act.